By submitting your electronic mail handle, you comply with Psychable collecting your information and facts in accordance with our Privateness Policy. You may unsubscribe Anytime.They prepare to finish this next phase III review by the tip of the year. After the section III is full, MAPS will submit an application for FDA approval for MDMA therapy.